STOCK TITAN
  1. Home
  2. Sec-filings
  3. RXRX
  4. [144] RECURSION PHARMACEUTICALS, INC. SEC Filing

Recursion (NASDAQ: RXRX) ex-director targets new 100K-share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

RECURSION PHARMACEUTICALS, INC. (RXRX) has a planned secondary sale of Class A common stock by former director Christopher C. Gibson under Rule 144. The notice covers up to 100,000 Class A shares, with an indicated aggregate market value of 327,500.00, to be sold through Fidelity Brokerage Services LLC on NASDAQ.

The disclosure also lists multiple prior Class A share sales in the past three months by Gibson, Lahwran-3 LLC, and the Gibson Family Trust, with Gibson identified as an authorized individual or trustee for those accounts.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 100000 shares Maximum number of RXRX Class A shares covered by the Form 144 notice
Aggregate market value of planned sale 327500.00 Approximate aggregate market value of the 100,000 Class A shares to be sold
Date of Notice 08/19/2026 Date on which the Form 144 notice was signed and submitted
Past sale 1 340440 shares for 1089541.29 Sale of RXRX Class A shares by Christopher C. Gibson on 06/18/2026
Past sale 2 100000 shares for 390028.58 Sale of RXRX Class A shares by Christopher C. Gibson on 07/07/2026
Past sale 3 186000 shares for 706094.96 Sale of RXRX Class A shares by Lahwran-3 LLC on 07/09/2026
Past sale 4 50000 shares for 195014.41 Sale of RXRX Class A shares by Gibson Family Trust on 07/07/2026
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Founders Shares financial
"Class A | 04/20/2021 | Founders Shares | Issuer"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
attorney-in-fact regulatory
"as attorney-in-fact for Christopher Gibson"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
Form 144 regulatory
"144: Securities Sold During The Past 3 Months"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What does the Form 144 filing mean for RECURSION PHARMACEUTICALS, INC. (RXRX)?
The Form 144 reports a planned resale of 100,000 Class A shares of RXRX by former director Christopher C. Gibson. It is a regulatory notice for potential sales under Rule 144 and does not involve the company issuing new shares or receiving proceeds.

How many RXRX shares does Christopher C. Gibson plan to sell under this Form 144?
The notice covers a proposed sale of up to 100,000 Class A shares of RXRX. The shares are described as founders shares, originally acquired from the issuer as compensation on 04/20/2021, and are to be sold through Fidelity Brokerage Services LLC.

What is the aggregate market value of the RXRX shares covered by this Form 144?
The filing lists an approximate aggregate market value of 327,500.00 for the 100,000 RXRX Class A shares. This figure reflects the market value used for the notice and is associated with sales to be executed on NASDAQ through Fidelity Brokerage Services LLC.

Which broker is handling the planned RXRX share sales in this Form 144?
The planned sale of 100,000 Class A shares of RXRX will be handled by Fidelity Brokerage Services LLC. The filing identifies Fidelity Brokerage Services LLC as the broker, with the shares expected to be sold on NASDAQ under Rule 144 requirements.

What prior RXRX stock sales by Christopher C. Gibson are disclosed in the past 3 months?
The filing lists several past three-month sales, including 340,440 shares on 06/18/2026 for 1,089,541.29 and 100,000 shares on 07/07/2026 for 390,028.58. Additional sales were made by Lahwran-3 LLC and the Gibson Family Trust accounts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR